Eton Pharmaceuticals, Inc.
ETON
$17.28
-$0.18-1.03%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.13M | -4.58M | -3.82M | -5.48M | -6.69M |
| Total Depreciation and Amortization | 2.65M | 1.93M | 1.15M | 1.12M | 1.03M |
| Total Amortization of Deferred Charges | 1.40M | 1.38M | 1.11M | 100.00K | 101.00K |
| Total Other Non-Cash Items | 7.22M | 4.76M | 3.24M | 3.20M | 3.21M |
| Change in Net Operating Assets | 5.10M | 2.06M | -698.00K | 3.19M | 2.39M |
| Cash from Operations | 12.24M | 5.53M | 969.00K | 2.12M | 42.00K |
| Capital Expenditure | -12.00K | -12.00K | -26.00K | -14.00K | -14.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -30.00M | -30.00M | -30.00M | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -8.12M | -8.12M | -9.99M | -2.64M | -2.64M |
| Cash from Investing | -38.13M | -38.13M | -40.01M | -2.66M | -2.66M |
| Total Debt Issued | 25.31M | 25.31M | 25.31M | -- | -- |
| Total Debt Repaid | -385.00K | -770.00K | -1.16M | -1.54M | -1.54M |
| Issuance of Common Stock | 8.66M | 8.83M | 8.44M | 267.00K | 283.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 33.58M | 33.37M | 32.59M | -1.27M | -1.26M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.69M | 765.00K | -6.45M | -1.81M | -3.87M |